40 to 44% cases are diagnosed at stage IIIB (Koh et al., 2019). Radiation is the mainstay of treatment for advance disease that localized within the pelvis, i.e stage IIB to IVA. Disease free survival after radiation is comparable to surgery performed in early stage (Koh et al., 2019). Furthermore, radiation can decrease the local recurrence after surgery in high risk patients. Response to radiation depends on histologic type, grade of differentiation, size, vascularization, and location of the tumor (Perez et al.,